Electrical stimulation of stem cell–derived human neural networks for evaluating anti‐seizure medications
Epilepsia · 2025-11 · 66 (11) · 4554-4572
DOI: 10.1111/epi.18560 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, online erschienen am 28.07.2025. Verfasst von Joshua Nicholls und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Faculty of Medicine, Nursing and Health Science, School of Translational Medicine, Monash University, Melbourne, Victoria…. Hauptthemen laut MEDLINE: Anticonvulsants, Induced Pluripotent Stem Cells, Electric Stimulation, Nerve Net. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Current preclinical epilepsy drug screening relies on animal models that poorly reflect human neurophysiology, leading to high failure rates in clinical translation. We aimed to establish a human in vitro model using human‐induced pluripotent stem cell (hiPSC)–derived cortical neurons cultured on multielectrode arrays (MEAs), capable of generating precisely controlled after‐discharges (ADs) through electrical stimulation. We optimized stimulation parameters to evoke epileptiform‐like hypersynchronous events and validated the model using six approved antiseizure medications (ASMs). Methods hiPSCs were rapidly differentiated into NGN2 cortical neurons and co‐cultured with astrocytes on a 12‐electrode, 24‐well MEA. Network activity was tracked weekly. Upon maturation, biphasic voltage stimuli (400–2000 mV, 10 pulses at 100 Hz, 100 μs phase width) were applied in 100 ms trains to induce ADs. Stimulation intensity was increased until a maximum spike count per burst was reached. The timing of the stimulating inter‐burst interval (IBI) was shortened from 10 to 1 s. We tested six ASMs with distinct mechanisms of action for their ability to attenuate induced ADs, as measured by the area under the curve (AUC) of spikes within bursts.
Results
A ±1000 mV stimulus was sufficient to evoke robust ADs; higher voltages caused network instability without enhancing response strength. The maximum hypersynchronous bursting rate was observed with 2 s IBIs, whereas attempts to induce more frequent events using 1 s IBIs led to desynchronization and a reduction in burst frequency below baseline. Phenytoin, perampanel, clonazepam, and lamotrigine significantly reduced AUC within 5 min in a concentration‐dependent manner. Vigabatrin and levetiracetam required longer pre‐incubations: AUC was reduced after 6 h for levetiracetam and at 24 h for vigabatrin. Significance We present a novel hiPSC‐derived, electrically induced in vitro model for screening ASM candidates. This approach captures human‐relevant epileptiform dynamics, allows fine control over stimulation parameters, and enables testing of diverse drug mechanisms. Its compatibility with high‐throughput platforms makes it a promising tool for ASM discovery and personalized treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Faculty of Medicine, Nursing and Health Science, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
- Australian Centre of Blood Diseases, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
- School of Pharmacy, Nanchang University, Nanchang, China.
- Department of Chemistry and Biotechnology, School of Science, Computing and Engineering Technologies, Swinburne University of Technology, Hawthorn, Victoria, Australia.
- Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.
- Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.
ORCID-Profile: Joshua Nicholls, Zhibin Chen, Zikou Liu, Ana Antonic-Baker, Muhammad Shahid Javaid, Hailin Zhu, David K Wright, Huseyin Sumer, Terence J O'Brien, Patrick Kwan, Ben Rollo
Zitieren
APA
Nicholls, J., Gu, J., Chen, Z., Liu, Z., Antonic-Baker, A., Javaid, M. S., Moore, E., Zhu, H., Altalhi, A., Wright, D. K., Sumer, H., O'Brien, T. J., Kwan, P., & Rollo, B. (2025). Electrical stimulation of stem cell–derived human neural networks for evaluating anti‐seizure medications. Epilepsia, 66(11), 4554-4572. https://doi.org/10.1111/epi.18560
Vancouver
Nicholls J, Gu J, Chen Z, Liu Z, Antonic-Baker A, Javaid MS, et al. Electrical stimulation of stem cell–derived human neural networks for evaluating anti‐seizure medications. Epilepsia. 2025;66(11):4554-4572. doi:10.1111/epi.18560
BibTeX
@article{Nicholls2025,
author = {Nicholls, Joshua and Gu, Jinchao and Chen, Zhibin and Liu, Zikou and Antonic-Baker, Ana and Javaid, Muhammad Shahid and Moore, Eliza and Zhu, Hailin and Altalhi, Afaf and Wright, David K and Sumer, Huseyin and O'Brien, Terence J and Kwan, Patrick and Rollo, Ben},
title = {Electrical stimulation of stem cell–derived human neural networks for evaluating anti‐seizure medications},
journal = {Epilepsia},
year = {2025},
volume = {66},
number = {11},
pages = {4554--4572},
doi = {10.1111/epi.18560}
}
EUVIMED